ImClone (IMCL) CFO Howerton Leaves, Names Ana Stancic To Position
More News related to IMCL
- Level 3 (LVLT) Expands Relationship with ImClone (IMCL)
- Does CV Therapeutics (CVTX) Have A Case of Merger-Cockiness?
- Top 15 For 2008 (No. 14): M&A Wreckage
- Top 10 News Items 10/6-10/10: Dow Plunges 18% This Week; UK to Inject Capital Into Banking System; Iceland Melts-down, Seizes Largest Bank
- Icahn Says Boards Need To Be Held Accountable
ImClone Systems (NASDAQ: IMCL) announced that Michael J. Howerton, Senior Vice President, Finance and Chief Financial Officer, has decided to leave the Company. ImClone said Mr. Howerton's decision was a personal decision and is not a reflection on the financial condition of the Company or any issues relating to financial controls.
ImClone announced that Ana I. Stancic, Vice President, Finance and Chief Accounting Officer, has been promoted to Senior Vice President, Finance.
Before joining the Company, Ms. Stancic was Vice President and Controller at Savient Pharmaceuticals, Inc. from 2003 to February 2004. Ms. Stancic was Vice President and Chief Accounting Officer at Ogden Corporation from 1999 to 2002 and Regional Chief Financial Officer at OmniCare, Inc. from 1997 to 1999.
Related Categories
Management ChangesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
